Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201505001141379Not yet recruiting
Randomised, open-label trial in Tuberculosis (TB) (2 arms), sponsored by University College London. Primary endpoint: TB disease-free survival at 72 weeks post-randomization. Planned start Jul 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201505001141379.